Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis

Blood

Volumn 91, Issue 4, 1998, Pages 1235-1242

  Dai, Chun Hua ^b   Price, James O ^b   Brunner, Thomas ^b   Krantz, Sanford B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON;

APOPTOSIS; ARTICLE; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL;

EID: 0032519537     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.4.1235     Document Type: Article

References (45)

1. Sen GC, Lengyel P: The interferon system. J Biol Chem 267: 5017, 1992
2. Zoumbos NC, Djeu JY, Young NS: Interferon is the suppresser of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 133:769, 1984
3. Klimpel GR, Fleischmann WR, Kumpel KD: Gamma Interferon (IFN-γ) and IFNoα/ βsuppress murine myeloid colony formation (CFU-C): Magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol 129:76, 1982
4. Koike K, Ma F, Shiohara M, Kubo T, Takagi M, Amano Y, Nakahata T, Komiyama A: Interferon-gamma inhibits proliferation, but not commitment, of murine granulocyte-macrophage progenitors. J Cell Physiol 153:528, 1992
5. Mamus SW, Beck-Schroeder S, Zanjani ED: Suppression of normal human erythropoiesis by gamma interferon in vitro: Role of monocytes and T-lymphocytes. J Clin Invest 75:1496, 1985
6. Means RT, Krantz SB: Inhibition of human erythroid colony-forming units by γ interferon can be corrected by recombinant human erythropoietin. Blood 78:2564, 1991
7. Means RT, Krantz SB, Luna J, Marters SA, Ashkenazi A: Inhibition of murine erythroid colony formation in vitro by interferon γ and correction by interferon receptor immunoadhesin. Blood 83:911, 1994
8. Dai C-H, Krantz SB, Koller K, Price JO: Stem cell factor can overcome inhibition of highly purified human burst-forming units-erythroid by interferon γ. J Cell Physiol 165:323, 1995
9. + human marrow cells is induced by interferon γ and tumor necrosis factor a and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
10. Grawunder U, Melchers F, Rolink A: Interferon-γ arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobin-positive B cells. Eur J Immunol 23:544, 1993
11. Groux H, Monte D, Plouvier B, Capron A, Ameisen J-C: CD-3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: Respective roles of interleukin-1, interleukin-2, interferon-γ and accessory cells. Eur J Immunol 23:1623, 1993
12. Muta K, Krantz SB: Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 156:264, 1993
13. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Path M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Baumler C, Hellbardt S, Germer M, Peter ME, Debatin K-M: The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:176, 1994
14. Ju S-T, Panka DJ, Cul H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
15. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
16. Takenaka K, Nagafuji K, Harada M, Mizuno S, Miyamoto T, Makino S, Gondo H, Okamura T, Niho Y: In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 88:2871, 1996
17. + cells of patients with aplastic anemia. Br J Haematol 91:245, 1995
18. Barcena A, Park SW, Banapour B, Muench MO, Mechetner E: Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 88:2013, 1996
19. Sawada K, Krantz SB, Kans JS, Dessypris EN, Sawyer S, Glick AD, Civin CI: Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 80:357, 1987
20. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
21. Wickrema A, Krantz SB, Winkelmann JC, Bondurant MC: Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80:1940, 1992
22. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
23. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol 6:1567, 1994
24. Muta K, Nishimura J, Ideguchi H, Umemura T, Ibayashi H: Erythroblast transferrin receptors and transferrin kinetics in iron deficiency and various anemias. Am J Hematol 25:155, 1987
25. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
26. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yushino K, Okumura K, Yagita H: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182:1777, 1995
27. Means RT, Dessypris EN, Krantz SB: Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 150:59, 1992
28. Taniguchi S, Dai C-H, Krantz SB. Specific binding of Interferon-γ to high affinity receptors on human erythroid colony-forming cells. Exp Hematol 25:193, 1997
29. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G. Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer PH: Purification and molecular cloning of the Apo-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709, 1992
30. Watanabe-Fukunaga, Brannan CJ, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274, 1992
31. Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M: Fas-mediated apoptosis in cultured human eosinophils. Blood 87:2822, 1996
32. Liles WC, Klebanoff SJ: Regulation of apoptosis in neutrophils -Fas track to death? J Immunol 155:3289, 1995
33. Min YH, Lee S, Lee JW, Chong SY, Hahn JS, Ko YW: Expression of Fas antigen in acute myeloid leukemia is associated with therapeutic response to chemotherapy. Br J Haematol 93:928, 1996
34. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
35. Suda T, Okazaki T, Naito Y, Yokota T, Aral N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806, 1995
36. Wilson SE, Li Q, Weng J, Barry-Lane PA, Jester JV, Liang Q, Wordinger RJ: The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Opthalmol Vis Sci 37:1582, 1996
37. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J-C, Tschopp J: Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape. Science 274:1363, 1996
38. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 2:317, 1996
39. Strand S, Hoffman WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremel W, Krammer PH, Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells -Mechanism of immune evasion? Nat Med 2:1361, 1996
40. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075. 1996
41. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960, 1997
42. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429, 1996
43. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129, 1995
44. Martinez-Lorenzo MJ, Alava MA, Anel A, Pineiro A, Naval J: Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89:511, 1996
45. Taniguchi S, Dai C-H, Krantz SB: Interferon γ downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor I receptors in human erythroid colony-forming cells. Blood 90:2244, 1997